Literature DB >> 11917808

The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century.

J Peter Cegielski1, Daniel P Chin, Marcos A Espinal, Thomas R Frieden, Rodolfo Rodriquez Cruz, Elizabeth A Talbot, Diana E C Weil, Richard Zaleskis, Mario C Raviglione.   

Abstract

Mycobacterium tuberculosis has been identified in prehistoric remains of humans. Despite references to TB by Hippocrates and Galen, humankind had limited understanding of and few tools to defend itself against TB until the later 19th century. Subsequently, landmark advances in the 20th century provided the means to control and prevent this disease. At the same time, epidemiological developments and fundamental problems related to human behavior, socioeconomic conditions, and political circumstances continue to thwart efforts to diminish the burden of suffering and death caused by TB. This article reviewed some of these issues including the global failure of TB control in the late 20th century, the worldwide emergence of drug-resistant TB, the extensive spread of HIV infection and its impact on TB incidence; and changing health care and political environments. The obstacles to TB control remain and will remain challenges in the coming years. Still, recent developments in immunology, biochemistry, and molecular biology suggest that new knowledge and tools are just around the corner. These will enhance the ability to conquer this microbe by the end of the current century.

Entities:  

Mesh:

Year:  2002        PMID: 11917808     DOI: 10.1016/s0891-5520(03)00045-x

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  15 in total

1.  Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.

Authors:  Adel M Talaat; Sarah K Ward; Chia-Wei Wu; Elizabeth Rondon; Christine Tavano; John P Bannantine; Rick Lyons; Stephen A Johnston
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

2.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The phosphoenolpyruvate carboxykinase of Mycobacterium tuberculosis induces strong cell-mediated immune responses in mice.

Authors:  Keyi Liu; Xuelian Ba; Jinzhi Yu; Jin Li; Qingkuan Wei; Guangdong Han; Guiping Li; Yong Cui
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

4.  Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin.

Authors:  Cynthia A Sanders; Rachel R Nieda; Edward P Desmond
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Computer-assisted detection (CAD) methodology for early detection of response to pharmaceutical therapy in tuberculosis patients.

Authors:  Robert Lieberman; Heston Kwong; Brent Liu; Hk Huang
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009

6.  Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.

Authors:  Steven C Derrick; Charlene Repique; Philip Snoy; Amy Li Yang; Sheldon Morris
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice.

Authors:  John L Dahl; Carl N Kraus; Helena I M Boshoff; Bernard Doan; Korrie Foley; David Avarbock; Gilla Kaplan; Valerie Mizrahi; Harvey Rubin; Clifton E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

8.  Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge.

Authors:  J D Colmenero; M E Jiménez-Mejías; J M Reguera; J Palomino-Nicás; J D Ruiz-Mesa; J Márquez-Rivas; A Lozano; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

9.  Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.

Authors:  Petros C Karakousis; Tetsuyuki Yoshimatsu; Gyanu Lamichhane; Samuel C Woolwine; Eric L Nuermberger; Jacques Grosset; William R Bishai
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

10.  Scale-up of multidrug-resistant tuberculosis laboratory services, Peru.

Authors:  Sonya S Shin; Martin Yagui; Luis Ascencios; Gloria Yale; Carmen Suarez; Neyda Quispe; Cesar Bonilla; Joaquin Blaya; Allison Taylor; Carmen Contreras; Peter Cegielski
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.